Mesothelioma therapeutic agent
US8802092B2 · kind B2 · utility
12Cited by
3References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2008 |
| Grant date | Aug 12, 2014 |
| Priority date | — |
| Expiry date | Apr 10, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a mesothelioma therapeutic agent containing an interleukin-6 (IL-6) antagonist such as antibody to IL-6 receptor (IL-6R), and a mesothelioma cell growth inhibitor containing an IL-6 antagonist such as antibody to IL-6R.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.